: iStockAnalyst.com Symbols Feed

ProActive HavRx Stock Indexes: Highlights And Opportunities

Sat, 07 Nov 2009 22:13:14 GMT

Below is a summary and some charts for popular and top performers among the 22 ProActive HavRx global stock indexes. Despite the FDA filing by Dendreon (NASDAQ: DNDN) during the past week, the underlying ImmunoTherapy / Vaccines Index is off to a slow start and down by about 10% since mid-October.[More...]

InvestmentNews: Health IT Investing, Index Mention

Thu, 05 Nov 2009 16:07:09 GMT

The Senior Editor of InvestmentNews, Jeff Benjamin, published an article today about investing in Healthcare Information Technology (Health IT) along with a reference to my Global Health IT Index and phone interview comments.[More...]

VICL, DNDN, BKD, RINO, ASPM, IFLO, HITK, AFFX: Seven Bullish Healthcare Stocks

Mon, 12 Oct 2009 15:35:00 GMT

Stocks in medical sector have been in the limelight for quite some time. Yesterday, I researched over 400 stocks in the medical sector.[More...]

16 Breakout Stocks On Unusually Big Volume: Sept 10, 2009

Thu, 10 Sep 2009 12:23:35 GMT

In this post are 16 stocks which I will be keeping an eye on at least until September options expiration. These stocks have showed great strength, breaking out to the upside on extremely large volume.[More...]

New Indexes To Track Healthcare Trends And More

Wed, 05 Aug 2009 15:34:05 GMT

Below are links and descriptions for 23 new stock indexes I have created, revised, and tracked over the past few years which are now featured at a new website called Investars YOU. The new site includes automated index tracking, allows investors to create custom stock portfolios based on their individual preferences, and now features free access to all of the component stocks in each of my indexes. Some of the top performing stocks from my healthcare indexes on a year-to-date basis (...)[More...]

Caraco Pharma Awaits FDA Inspection

Fri, 30 Jan 2009 21:29:00 GMT

With shares of Hi-Tech Pharmacal (HITK) already up about 20% since I profiled the Company as a value play two days ago, investors interested in the small-cap generic drug industry should take a look at Caraco Pharma (CPD) today at around 5 bucks. CPD reported results for its fiscal 3Q09 yesterday, including $55.7M in revenue and net income of $5.1M, which was down from the year-ago period revenue of $81.9M and net income of $10.8M. The year-ago period benefited substantially from the 180-day exclusivity period associated with the generic drug launch of oxcarbazepine (Trileptal) in conjunction with Sun Pharma (India: 524715). Caraco noted that full-year revenue for fiscal 2009 is expected to be about the same as the previous year, reflecting uncertainty over the at-risk launch of generic Protonix (pantoprazole) and lower sales of oxcarbazepine since[More...]

Hi-Tech Pharmacal: Hi-Growth at a Value Price

Wed, 28 Jan 2009 18:05:00 GMT

With shares of Home Diagnostics (HDIX) surging by nearly 50% since I profiled the company in mid-December as a turnaround, value play from the ETF Innovators Healthcare Cost Containment Index; a search for compelling values among these companies today led me to generic drug maker Hi-Tech[More...]

Beyond Stem Cells: Healthcare Hot Spots

Mon, 26 Jan 2009 18:09:00 GMT

With the surprise announcement last week by Geron (GERN) that the FDA would allow human clinical trials for embryonic stem cells, all companies in the underlying ETF Innovators Index to track the space are screaming higher again today – led by the company with the biggest gains over the past year, StemCells (STEM). Below are three additional areas and associated companies for investors to consider in the search of the next hot spots in the healthcare sector, including a focus on small/mid-cap companies which have the added potential to be acquired as part of renewed M&A in the sector this year. Molecular Diagnostics EXACT Sciences (EXAS) has rejected the hostile $1.50 all-stock offer from[More...]

Look For Laggards After Latest Market Rally

Tue, 09 Dec 2008 13:09:00 GMT

With the S&P 500 SPDR (SPY) trading to the upside by more than 10% in the last five days on the prospects for a short-term $15B rescue package for U.S. auto makers to prevent rising unemployment rates from skyrocketing into double digits, Caraco Pharma (CPD) and Altria Group (MO) represent two laggards from defensive industry groups. The accompanying one-month chart (click to enlarge) illustrates a highly correlated sell-off in Caraco and another small generic drug[More...]

Generic Cardio Drugs Equal Brands

Tue, 02 Dec 2008 22:24:00 GMT

A meta-analysis review of clinical studies published in peer-reviewed journals was featured today in The Journal of the American Medical Association (JAMA) and concluded that cost-saving generics used to treat a variety of cardiovascular conditions produced equivalent clinical outcomes to higher cost brand name drugs. Despite this clinical evidence, the review notes that a majority (53%) of the 43 editorials analyzed had a negative opinion on generic substitution. While there are currently no ETFs on the market which feature generic drug companies, the ETF Innovators (ETFI)[More...]

CEA Names 2009 Mark of Excellence Award Winners

Wed, 18 Mar 2009 14:47:00 GMT

The Consumer Electronics Association (CEA) has announced the winners of the 2009 Mark of Excellence Awards, presented by CEA's TechHome Division.
CEA said its Mark of Excellence Awards honor achievement in custom home electronics products, services and installation technologies.
Award entries were reviewed by a panel of industry executives and submitted in Supplier, Training and Support and Systems Integrators categories.

: iStockAnalyst.com Symbols Feed

ProActive HavRx Stock Indexes: Highlights And Opportunities

InvestmentNews: Health IT Investing, Index Mention

VICL, DNDN, BKD, RINO, ASPM, IFLO, HITK, AFFX: Seven Bullish Healthcare Stocks

16 Breakout Stocks On Unusually Big Volume: Sept 10, 2009

New Indexes To Track Healthcare Trends And More

Caraco Pharma Awaits FDA Inspection

Hi-Tech Pharmacal: Hi-Growth at a Value Price

Beyond Stem Cells: Healthcare Hot Spots

Look For Laggards After Latest Market Rally

Generic Cardio Drugs Equal Brands

CEA Names 2009 Mark of Excellence Award Winners

Hi-Tech Pharmacal Q3 Net Sales Up 95%

Keep Safe on the Internet

Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2009

The M&Amp;A Advisor Announces Finalists for First Annual Global M&Amp;A Awards

Microchip Technology Rolls Out First PIC® Microcontrollers Featuring Enhanced Mid-Range 8-Bit Core

New Family of Low-Power 8-Bit PIC® Microcontrollers With nanoWatt XLP Technology Unveiled By Microchip Technology

Hi-Tech Pharmacal Reports 83% Increase in Sales for the Fourth Fiscal Quarter 2009

Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 14, 2009

Hi-Tech Pharmacal to Present at the 8th Annual Needham Life Sciences Conference

Microchip Technology Celebrates 5-Year Anniversary of PIC10F 8-Bit Microcontrollers (MCUs)

Microchip Technology Unveils PICDEM(TM) Lab Development Kit

CEA Announces 2009 Mark of Excellence Award Winners - Mar 16 2009 11:51PM

Form 4 HIRSHAUT YASHAR For: Oct 14 (10K)

Form 4 SELTZER REUBEN For: Oct 14 (10K)

Form 4 PETERS WILLIAM J For: Oct 13 (10K)

Form 4 SELTZER DAVID S For: Oct 07 (10K)

Form 4 PETERS WILLIAM J For: Oct 05 (10K)

Form 4 PETERS WILLIAM J For: Sep 30 (10K)

Form 4 GOLDWYN MARTIN M For: Sep 30 (10K)

Form 4 SELTZER REUBEN For: Sep 29 (10K)

Form 4 SELTZER DAVID S For: Sep 29 (10K)

Form 4 April Gary M For: Sep 15 (10K)